News | February 17, 2015

Baby’s Heart Defect Detected by 2-Minute Screening Test

Procedure now required for all newborns in Michigan

University of Michigan, heart defect, baby, screening test

February 17, 2015 — Thanks to a two-minute newborn screening test designed to help detect heart defects, a Michigan couple was made aware of their newborn daughter’s unexpected heart defect. The test is now a requirement in hospitals throughout Michigan.

At birth, Payton was the image of perfect health. But just minutes before parents Holly and Rob Morris of Quincy, Mich., expected to take her home from Hillsdale Community Health Center, they learned Payton had failed a newborn screening test designed to help detect heart defects.

The couple was shocked. There were no signs of trouble throughout the pregnancy that included regular prenatal care and recommended screenings.

The test showed that Payton had abnormally low oxygen levels. Hillsdale pediatrician Hugh Brainard, M.D., and his team acted quickly to get Payton transferred to University of Michigan’s C.S. Mott Children's Hospital where she was officially diagnosed with a critical congenital heart defect that is among the most difficult to detect before birth.

As the state recognizes Michigan Congenital Heart Defect Awareness week in February and the 50th anniversary of Michigan’s Newborn Screening Program this year, Payton’s case highlights the importance of the state’s new screening requirement for all Michigan birthing centers to screen for heart defects using pulse oximetry at 24 hours of life. The mandate took effect in April 2014 and the Michigan Department of Community Health, collaborating with U-M and others, created the tools needed for birthing centers and midwives to implement the screening.

“Payton’s diagnosis was a direct result of the newborn screening program,” says Ronald Grifka, M.D., pediatric cardiologist at U-M’s C.S. Mott Children’s Hospital.

"Her case underlines why this screening program became mandatory – so that we can detect significant heart defects that may not cause any symptoms before a newborn is discharged from the hospital. This early detection screening prevents babies from leaving the hospital with their parents assuming all is well, then becoming critically ill at home.

“We are pleased that our Michigan Congenital Heart Center team was able to diagnose Payton’s heart problem and promptly get her the care she needed.”

U-M’s C.S. Mott Children’s Hospital has routinely offered the newborn screening since 2003. While this screening cannot detect all heart defects, it ensures that more babies can receive immediate care if the pulse oximetry test shows that their oxygen levels are not normal.

Payton was diagnosed with total anomalous pulmonary venous return (TAPVR), which means that oxygen-rich blood does not return from the lungs to the left atrium like it’s supposed to. This is one of several specific critical heart defects that may be detected by newborn screening since it is not always possible to diagnose these defects before birth.

For more information:

Related Content

First-in-Human Results Show Early Bird Device Effective in Early Detection of Internal Bleeding
News | Patient Monitors | June 18, 2019
New study results validate the effectiveness of the Saranas Early Bird Bleed Monitoring System to sense bleeding events...
Lexington Biosciences Concludes Initial HeartSentry Clinical Study
News | Patient Monitors | August 16, 2018
Lexington Biosciences Inc. recently announced the completion of the initial HeartSentry study conducted at San...
Itamar Medical Launches SleePath for AFib Patients at Heart Rhythm 2018
Technology | Patient Monitors | May 16, 2018
Itamar Medical Ltd. announced the launch of SleePath, the first integrated e-health sleep apnea care pathway monitoring...
News | Patient Monitors | March 09, 2018
Philips recently announced the integration of its IntelliVue Guardian with automated Early Warning Scoring (EWS) into...
Acarix, CADScor System, coronary artery disease detection, clinical study, ACC.17
News | Patient Monitors | March 30, 2017
Acarix AB recently announced the results from a new multi-center trial of its handheld CADScor System for non-invasive...
Corsens Medical, Corsens Cardiac Monitor, FDA 510(k) clearance
Technology | Patient Monitors | December 08, 2016
Corsens Medical Ltd. announced that it has received clearance for a Pre-Marketing Notification (510(k)) with the U.S....
Corsens Cardiac Monitor, FDA 510k pre-market notification
News | Patient Monitors | May 26, 2016
Corsens Medical Ltd. announced it has successfully completed filing of a Pre-Marketing Notification (510(k)) with the U...
Philips, FDA 510k clearance, Expression MR400, MRI patient monitor
Technology | Patient Monitors | February 11, 2016
Royal Philips announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Expression MR400, a new...
Profusa, integrated biosensors, long-term continuous monitoring
News | Patient Monitors | January 15, 2016
Biointegrated sensors for long-term, continuous tracking of body chemistry may make health and disease monitoring as...
sleep apnea, pulse oximetery, congestive heart failure, CHF, pulse-oximetry, Thomas Jefferson University
News | Patient Monitors | September 09, 2015
Researchers at Thomas Jefferson University showed that a simple questionnaire, evaluation and pulse-oximetry monitoring...